Soft tissue sarcomas of the hand: functional reconstruction and outcome analysis.
Functional hand reconstruction following treatment of soft tissue sarcomas (STS) is a difficult surgical problem. Because survival rates between amputation and limb salvage do not differ, there is a trend toward reconstruction. Unlike amputation, hand salvage usually requires multiple complex operations in combination with adjuvant radiation or chemotherapy, prolonged rehabilitation, and carries a high complication rate. We investigated tumor recurrence, survival, and scored functional outcomes to determine if limb salvage is justified after hand STS resection. Patients treated for hand STS between years 1985 and 2005 were reviewed by two surgeons in three medical centers. All patients having functional reconstruction instead of amputation were reviewed. Patient demographics, tumor type and grade, resection extent, reconstruction procedure, timing, adjuvant therapy use, complications, tumor recurrence, survival, and functional outcome were recorded and analyzed. Five patients underwent functional reconstruction for hand STS. All patients underwent attempted curative resections, and four patients received neoadjuvant or postoperative radiation therapy. Three patients received adjuvant chemotherapy. Reconstructive techniques included three modified pollicizations, one free-tissue transfer, and one groin flap. All patients were alive and disease-free at a mean follow-up of 5 years (range 1.5-17 years). Three patients (60%) had local complications, requiring secondary surgeries. Two complications were related to radiation therapy. Hand function was evaluated using the Enneking Scoring System, and ranged from 17 to 28. The average Enneking score was 22.4, representing an average preservation of 74.6% of function. Because most patients retain excellent function and survival is unaffected, we advocate functional reconstruction despite high complication rates.
Labow
Brian I
BI
Divisions of Plastic Surgery, Beth Israel Deaconess Medical Center, Boston, MA, USA. brian.labow@childrens.harvard.edu
Rosen
Heather
H
Greene
Arin K
AK
Lee
W P Andrew
WP
Upton
Joseph
J
J Bone Joint Surg Am. 1995 Apr;77(4):564-71
7713973
Clin Orthop Relat Res. 1996 Jul;(328):91-3
8653984
J Surg Oncol. 1996 Feb;61(2):90-9
8606553
Hand Clin. 2004 Aug;20(3):325-33, vii
15275691
Int J Radiat Oncol Biol Phys. 2000 Nov 1;48(4):1051-8
11072162
Cancer. 2002 Aug 15;95(4):852-61
12209730
Scand J Plast Reconstr Surg Hand Surg. 1996 Mar;30(1):75-8
8711448
Hand Clin. 2004 May;20(2):vi, 221-5
15201026
Ann Surg. 1982 Sep;196(3):305-15
7114936
Clin Orthop Relat Res. 1993 Jan;(286):241-6
8425352
Cancer. 1993 Aug 15;72(4):1230-8
8339214
Hand Clin. 1995 May;11(2):287-305
7635888
Cancer. 2006 Nov 15;107(10):2455-61
17036354
J Hand Surg Am. 1997 May;22(3):495-503
9195461
Hand Clin. 2004 May;20(2):vi, 181-202
15201023
Surg Oncol Clin N Am. 1996 Oct;5(4):847-92
8899948
J Surg Oncol. 2007 Feb 1;95(2):135-41
17262730
J Hand Surg Br. 1994 Aug;19(4):411-9
7964087
Ann Surg Oncol. 2004 Oct;11(10):921-7
15466352